Last deal

$50M

Amount

Post-IPO Equity

Stage

21.12.2023

Date

3

all rounds

$225.02M

Total amount

date founded

Financing round

General

About Company
Shattuck Labs is a biotech company that develops innovative biologic medicines for cancer and autoimmune diseases.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2016

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

Shattuck Labs is a clinical-stage biotech company pioneering the development of dual-function fusion proteins called Agonist Redirected Checkpoints (ARC). Their lead programs, SL-279252 and SL-172154, are being evaluated in Phase 1 trials. These programs are designed to simultaneously inhibit checkpoint molecules and activate costimulatory molecules, offering potential treatment options for various cancer types. Shattuck's technology aims to provide quick and painless detection of malignancy for later-stage cancer patients. Additionally, the company is working on a proprietary Gamma Delta T Cell Engager (GADLEN™) platform for cancer treatment. With offices in Austin, Texas, and Durham, North Carolina, Shattuck Labs is at the forefront of developing biologic medicines for cancer and autoimmune diseases.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Vaxil Bio

Vaxil Bio

Vaxil Bio is an Israeli biotech company focused on developing innovative cancer treatments using immuno-oncology.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Toronto, ON, Canada
ImmuNext

ImmuNext

ImmuNext is a biotech company that develops compounds for cutting-edge immunotherapy for cancer and autoimmune diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

West Lebanon, Lebanon, NH 03784, USA
OncoSec Medical

OncoSec Medical

OncoSec is a biotech company that develops innovative technologies to stimulate the immune system to attack cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

San Diego, CA, USA

total rounds

12

total raised

$142.59M
ImmunoGen

ImmunoGen

ImmunoGen is a clinical-stage biotechnology company that develops antibody-based anticancer therapeutics.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Waltham, MA, USA

total rounds

7

total raised

$300.5M

Financials

Funding Rounds
5
3

Number of Funding Rounds

$225.02M

Money Raised

Their latest funding was raised on 21.12.2023. Their latest round Post-IPO Equity

Date 
Funding Round 
Investors 
Money Raised 
Lead 
21.12.2023
$50M
15.06.2020
9
$118M
24.05.2018
$46.62M
Redmile Group

Redmile Group

Redmile Group is a San Francisco-based healthcare investment company.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Health Care, Venture Capital, Financial Services

Location

San Francisco, CA, USA

count Of Investments

143

count Of Exists

16
Co-Investors
Investors
9
1

Number of lead investors

9

Number of investors

Investor 
Lead 
Round 
Partners 
No
Series B
No
Series B
Partner Fund Management

Partner Fund Management

Partner Fund Management offers services to investment funds.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

San Francisco, CA, USA

count Of Investments

23

count Of Exists

6
Emerson Collective

Emerson Collective

Emerson Collective removes barriers to opportunity for people's full potential.

Sector

Industrial Support Services

Subsector

Professional Business Support Services

Keywords

Non-Profit

Location

Palo Alto, CA, USA

count Of Investments

105

count Of Exists

9
Avidity Partners

Avidity Partners

Avidity Partners is an investment management firm that offers financial services.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Keywords

Financial Services, Finance

count Of Investments

51

count Of Exists

1

People

Founders
2
Taylor Schreiber
Taylor Schreiber

Taylor Schreiber

current job

Shattuck Labs
Shattuck Labs

organization founded

2

Taylor Schreiber

Josiah Hornblower
Josiah Hornblower

Josiah Hornblower

In addition to serving as Managing Member of Pilgrims & Indians, Josiah has been a Managing Member of Blue Pine Partners, LLC since 2008, an investment and advisory firm that he founded in the community bank sector. From 2004 to 2008, Josiah was a principal of Resource Financial Institutions Group, Inc. (RFIG), a manager of private equity funds focused on investing in community banks. During that period, he served on the Board of Directors of Pacific Enterprise Bancorp, an Orange County, California-based commercial bank. Before joining RFIG, Josiah worked as an equity analyst at Gray Seifert and Co., an investment management firm specializing in financial services, and at Barrett Associates, Inc. At both firms, he researched and invested in regional banks and financial technology companies. Josiah was a director of Portland, Oregon-based Capital Pacific Bank until its purchase by Pacific Continental Corporation (NASDAQ: PCBK) in 2015. Josiah currently serves on the boards of Pelican Therapeutics, Inc. and Population Diagnostics, Inc, and serves as CEO of Shattuck Labs, Inc. Josiah graduated with a Bachelor of Arts degree from Trinity College and was a member of Phi Beta Kappa. He resides in Austin, Texas.

current job

Shattuck Labs
Shattuck Labs

organization founded

2

Josiah Hornblower

Employee Profiles
6
Josiah Hornblower

Josiah Hornblower

Founder & Executive Chairman

Taylor Schreiber

Taylor Schreiber

Chief Executive Officer & Co-founder

Conor Richardson

Director of finance

Lini Pandite

Lini Pandite

Chief Medical Officer

Andrew R. Neill

Andrew R. Neill

Vice President of Corporate Development & Strategy

Activity

Recent News
3
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

month